Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Chevron
CVX
|
+$331M |
| 2 |
Walmart
WMT
|
+$229M |
| 3 |
Linde
LIN
|
+$187M |
| 4 |
PayPal
PYPL
|
+$145M |
| 5 |
Union Pacific
UNP
|
+$126M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$903M |
| 2 |
Uber
UBER
|
+$565M |
| 3 |
Exxon Mobil
XOM
|
+$450M |
| 4 |
Novo Nordisk
NVO
|
+$393M |
| 5 |
Apple
AAPL
|
+$317M |
Sector Composition
| 1 | Technology | 18.82% |
| 2 | Healthcare | 17.05% |
| 3 | Consumer Discretionary | 13.22% |
| 4 | Financials | 8.79% |
| 5 | Consumer Staples | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2751
KVH Industries
KVHI
$119M
| $652K | ﹤0.01% |
127,800
-7,600
| -6% | -$38.8K |
|
|
KLRS
2752
Kalaris Therapeutics, Inc. Common Stock
KLRS
$72.8M
| $650K | ﹤0.01% |
37,456
+4,327
| +13% | +$75.1K |
|
2753
Phillips Edison & Co
PECO
$4.47B
| $649K | ﹤0.01% |
+18,102
| New | +$649K |
|
2754
Installed Building Products
IBP
$7.27B
| $647K | ﹤0.01% |
+2,500
| New | +$647K |
|
2755
Hennessy Advisors
HNNA
$90.3M
| $647K | ﹤0.01% |
93,775
-247
| -0.3% | -$1.7K |
|
2756
Genelux
GNLX
$149M
| $646K | ﹤0.01% |
+100,400
| New | +$646K |
|
2757
Integral Ad Science
IAS
$1.4B
| $646K | ﹤0.01% |
64,800
-413,900
| -86% | -$4.13M |
|
2758
Spire Global
SPIR
$307M
| $645K | ﹤0.01% |
53,757
+13,900
| +35% | +$167K |
|
|
THRD
2759
DELISTED
Third Harmonic Bio
THRD
| $645K | ﹤0.01% |
68,300
+55,300
| +425% | +$522K |
|
2760
Urban One Class D
UONEK
$34.6M
| $644K | ﹤0.01% |
315,491
+76,086
| +32% | +$155K |
|
2761
ATS Corp
ATS
$2.63B
| $643K | ﹤0.01% |
19,100
-16,200
| -46% | -$545K |
|
2762
Chicago Rivet & Machine Co
CVR
$9.47M
| $643K | ﹤0.01% |
37,810
-800
| -2% | -$13.6K |
|
2763
Verint Systems
VRNT
$1.23B
| $643K | ﹤0.01% |
+19,408
| New | +$643K |
|
2764
SPDR Dow Jones REIT ETF
RWR
$1.88B
| $641K | ﹤0.01% |
+6,800
| New | +$641K |
|
|
SYRS
2765
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $641K | ﹤0.01% |
119,835
+61,200
| +104% | +$327K |
|
2766
VanEck Preferred Securities ex Financials ETF
PFXF
$1.91B
| $632K | ﹤0.01% |
35,700
+25,178
| +239% | +$446K |
|
2767
Cambium Networks
CMBM
$20.4M
| $631K | ﹤0.01% |
146,400
-83,600
| -36% | -$360K |
|
2768
CVD Equipment Corp
CVV
$21.1M
| $631K | ﹤0.01% |
133,982
-2,500
| -2% | -$11.8K |
|
|
AHT
2769
Ashford Hospitality Trust
AHT
$38.1M
| $630K | ﹤0.01% |
45,980
-13,494
| -23% | -$185K |
|
2770
Pyxis Oncology
PYXS
$113M
| $630K | ﹤0.01% |
148,000
-216,150
| -59% | -$920K |
|
2771
Lesaka Technologies
LSAK
$362M
| $628K | ﹤0.01% |
167,400
+8,124
| +5% | +$30.5K |
|
2772
Cardlytics
CDLX
$59.6M
| $626K | ﹤0.01% |
43,235
-97,600
| -69% | -$1.41M |
|
2773
CG Oncology
CGON
$2.54B
| $623K | ﹤0.01% |
+14,200
| New | +$623K |
|
2774
VanEck Rare Earth/Strategic Metals ETF
REMX
$735M
| $621K | ﹤0.01% |
12,100
-5,835
| -33% | -$299K |
|
2775
Schwab US Large-Cap Growth ETF
SCHG
$49.5B
| $621K | ﹤0.01% |
26,800
-51,600
| -66% | -$1.2M |
|